A method of diagnosing, prognosing, staging, and/or monitoring a mammalian amyloidogenic disorder or a predisposition thereto by detecting a protein or polypeptide aggregate in the cortical and/or supranuclear regions of an ocular lens of the mammal.

 
Web www.patentalert.com

< Energy management of a video capsule

< Sensor for transcutaneous measurement of vascular access blood flow

> Tissue interrogation spectroscopy

> Optical imaging of blood circulation velocities

~ 00288